<DOC>
	<DOC>NCT00739050</DOC>
	<brief_summary>Women with Systemic Lupus Erythematosus (SLE) are prone to cardiovascular disease. Early detection of improvement of endothelial function with simvastatin could be a clue for future intervention trials.</brief_summary>
	<brief_title>Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus, Systemic</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Female Patients Over 18 Years Old Confirmed Systemic Lupus Erythematosus (SLE) diagnosis according to American College of Rheumatology (ACR) Signed Informed Consent Form (ICF) Patients With LDLC Below 90 mg/dL Pregnant Or Breast Feeding Diabetes Mellitus Or Any Clinically Relevant Organ Disfunction</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>